MRK Merck & Co. Gross Profit Rate

Corporate emblem and logo of Merck & Co., Inc. (MRK)

Stable demand for vital vaccines and medicines ensures the production resilience of Merck & Co., Inc. (MRK). The gross margin share of revenue reflects current dynamics, with the indicator standing at 71.40. The company relies on the massive cash flows from Keytruda, offsetting patent risks by acquiring biotech startups to expand into cardiology and the treatment of rare pathologies.

Merck & Co., Inc. (MRK): Gross Profitability from 07/04/2022 to 11/19/2026

Analytical breakdowns for Merck & Co., Inc.

- stock value and consensus price forecast:
- market capitalization data:
Summary company analysis:Merck (MRK)
Manufactured products of Merck & Co.

Gross margin determines the share of profit after deducting direct production costs, characterizing the efficiency of the operating model. Analyzing the actual gross margin allows for filtering out market noise and assessing the fundamental resilience of the business. A high percentage indicates high product value-add and the issuer's pricing power. For Merck & Co., Inc. (MRK), this confirms management's proficiency in commercializing oncology drugs, despite the necessity of portfolio diversification.